Bright Minds Biosciences (DRUG) Return on Capital Employed [ROCE] (2024 - 2026)
Bright Minds Biosciences (DRUG) posted Return on Capital Employed [ROCE] of -13.09% for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.18 percentage points from 12.09% a year earlier but up 1.72 percentage points from the prior quarter.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Return on Capital Employed [ROCE] (2024 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Bright Minds Biosciences' Return on Capital Employed [ROCE] came in at -31.88%, up 15.22 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] has increased for three consecutive fiscal years, with a three-year change of +101841277.34 percentage points (FY2022 to FY2025).
- In prior fiscal years, Bright Minds Biosciences' Return on Capital Employed [ROCE] was -47.10% in FY2024 (+29.96 pp), -77.06% in FY2023 (+101841232.16 pp) and -101841309.22% in FY2022.
- Quarterly Return on Capital Employed [ROCE] has run from a low of -171.00% in fiscal Q2 2024 to a high of 12.09% in fiscal Q3 2025 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of +54.60 percentage points over the last six quarters.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior fiscal quarters was -14.81% (Q2 2026), -15.04% (Q1 2026) and -6.88% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Bright Minds Biosciences | 387.06 Mn | 387.06 Mn | - | -13.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.09% |
| Mar 31, 2026 | -14.81% |
| Dec 31, 2025 | -15.04% |
| Sep 30, 2025 | -6.88% |
| Jun 30, 2025 | 12.09% |
| Mar 31, 2025 | 1.15% |
| Dec 31, 2024 | -6.40% |
| Sep 30, 2024 | -65.86% |
| Jun 30, 2024 | -134.12% |
| Mar 31, 2024 | -171.00% |
API Access
Bright Minds Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();